Skip to content
411 PRESS
Hospital operating room medical equipment — representative photo for FDA medical device recall

A hospital operating room with medical equipment (representative file photo). Specific recalled device: see recall details below. Photo: FDA / Public Domain.

Recall Database

Medical Device Defects Recalls

Every record in this hub — all 304 — is an FDA medical-device recall. These are the devices used in hospitals, clinics, and homes: infusion and delivery systems, catheters, implants, imaging and monitoring equipment, surgical instruments, and reprocessed single-use devices. A record lands here when the recall text points to a device malfunction, a design or manufacturing defect, a labeling error, or a sterility or packaging failure.

Almost all of these notices are recent: 303 of the 304 were published in 2026, with the balance in 2025. That reflects the current FDA ingestion window, not the full history of device recalls — read the scope note below before treating the count as a total.

Use this hub to look up a device by manufacturer or model. Every row links to the FDA enforcement record, which carries the recall classification and the firm's corrective action.

304 recall records
Years 2025–2026
By agency FDA 304
Data through Apr 14, 2026

How this hub is built. This page groups the 304 recall records that 411 Press classifies as Medical Device Defects. Each record gets one primary hazard from a fixed, published rule set (taxonomy version 2026-07-28.C2.2); a record can carry secondary hazard tags but appears on only one hub. Regulators in this hub: FDA (304). These notices were published 2025–2026. This is not an all-time archive — it is the current dataset, drawn from CPSC, FDA, and NHTSA notices captured through late May 2026 (CPSC and NHTSA refreshed May 27, FDA May 28, 2026), and it grows as new notices are ingested. Every row links to the original agency notice. The agency's record is the authority; the hazard grouping is ours.

2026 (303)

  • FDAClass II

    Philips Upgrade to MR 7700 with MR Elastography (MRE).

    The potential for stiffness value errors when a specific range of image reconstruction parameters is used in combination with Resoundant's algorithm, leading to the reconstruction voxel size settings in the default MRE scan protocol displaying too small.

  • FDAClass II

    Philips SmartPath to Ingenia Elition X with MR Elastography (MRE).

    The potential for stiffness value errors when a specific range of image reconstruction parameters is used in combination with Resoundant's algorithm, leading to the reconstruction voxel size settings in the default MRE scan protocol displaying too small.

  • FDAClass II

    Philips SmartPath to dStream for XR and 3.0T with MR Elastography (MRE). 1. Model Number (REF): 781270. 2.

    The potential for stiffness value errors when a specific range of image reconstruction parameters is used in combination with Resoundant's algorithm, leading to the reconstruction voxel size settings in the default MRE scan protocol displaying too small.

  • FDAClass II

    Philips SmartPath to dStream for 3.0T with MR Elastography (MRE). 1. Model Number (REF): 782145.

    The potential for stiffness value errors when a specific range of image reconstruction parameters is used in combination with Resoundant's algorithm, leading to the reconstruction voxel size settings in the default MRE scan protocol displaying too small.

  • FDAClass II

    Philips SmartPath to dStream for 1.5T with MR Elastography (MRE). 1. Model Number (REF): 781260. 2. Model

    The potential for stiffness value errors when a specific range of image reconstruction parameters is used in combination with Resoundant's algorithm, leading to the reconstruction voxel size settings in the default MRE scan protocol displaying too small.

  • FDAClass II

    Philips MR 7700 with MR Elastography (MRE).

    The potential for stiffness value errors when a specific range of image reconstruction parameters is used in combination with Resoundant's algorithm, leading to the reconstruction voxel size settings in the default MRE scan protocol displaying too small.

  • FDAClass II

    Philips Ingenia Elition X with MR Elastography (MRE).

    The potential for stiffness value errors when a specific range of image reconstruction parameters is used in combination with Resoundant's algorithm, leading to the reconstruction voxel size settings in the default MRE scan protocol displaying too small.

  • FDAClass II

    Philips Ingenia Elition S with MR Elastography (MRE).

    The potential for stiffness value errors when a specific range of image reconstruction parameters is used in combination with Resoundant's algorithm, leading to the reconstruction voxel size settings in the default MRE scan protocol displaying too small.

  • FDAClass II

    Philips Ingenia Ambition X with MR Elastography (MRE).

    The potential for stiffness value errors when a specific range of image reconstruction parameters is used in combination with Resoundant's algorithm, leading to the reconstruction voxel size settings in the default MRE scan protocol displaying too small.

  • FDAClass II

    Philips Ingenia Ambition S with MR Elastography (MRE).

    The potential for stiffness value errors when a specific range of image reconstruction parameters is used in combination with Resoundant's algorithm, leading to the reconstruction voxel size settings in the default MRE scan protocol displaying too small.

  • FDAClass II

    Philips Ingenia 3.0T CX with MR Elastography (MRE). 1. Model Number (REF): 781271. 2. Model Number (REF):

    The potential for stiffness value errors when a specific range of image reconstruction parameters is used in combination with Resoundant's algorithm, leading to the reconstruction voxel size settings in the default MRE scan protocol displaying too small.

  • FDAClass II

    Philips Ingenia 3.0T with MR Elastography (MRE). 1. Model Number (REF): 781342. 2. Model Number (REF):

    The potential for stiffness value errors when a specific range of image reconstruction parameters is used in combination with Resoundant's algorithm, leading to the reconstruction voxel size settings in the default MRE scan protocol displaying too small.

  • FDAClass II

    Philips Ingenia 1.5T CX with MR Elastography (MRE). 1. Model Number (REF): 781262.

    The potential for stiffness value errors when a specific range of image reconstruction parameters is used in combination with Resoundant's algorithm, leading to the reconstruction voxel size settings in the default MRE scan protocol displaying too small.

  • FDAClass II

    Philips Ingenia 1.5T with MR Elastography (MRE). 1. Model Number (REF): 781315. 2. Model Number (REF):

    The potential for stiffness value errors when a specific range of image reconstruction parameters is used in combination with Resoundant's algorithm, leading to the reconstruction voxel size settings in the default MRE scan protocol displaying too small.

  • FDAClass II

    Philips Evolution upgrade 3.0T with MR Elastography (MRE). 1. Model Number (REF): 782143. 2. Model Number

    The potential for stiffness value errors when a specific range of image reconstruction parameters is used in combination with Resoundant's algorithm, leading to the reconstruction voxel size settings in the default MRE scan protocol displaying too small.

  • FDAClass II

    Philips Evolution Upgrade 1.5T with MR Elastography (MRE). 1. Model Number (REF): 782116 2. Model Number

    The potential for stiffness value errors when a specific range of image reconstruction parameters is used in combination with Resoundant's algorithm, leading to the reconstruction voxel size settings in the default MRE scan protocol displaying too small.

  • FDAClass II

    Philips Achieva 3.0T with MR Elastography (MRE). 1. Model Number (REF): 781278.

    The potential for stiffness value errors when a specific range of image reconstruction parameters is used in combination with Resoundant's algorithm, leading to the reconstruction voxel size settings in the default MRE scan protocol displaying too small.

  • FDAClass II

    Philips Achieva 1.5T Initial system with MR Elastography (MRE). 1. Model Number (REF): 781178.

    The potential for stiffness value errors when a specific range of image reconstruction parameters is used in combination with Resoundant's algorithm, leading to the reconstruction voxel size settings in the default MRE scan protocol displaying too small.

  • FDAClass II

    Philips Achieva 1.5T with MR Elastography (MRE). 1. Model Number (REF): 781196. 2. Model Number (REF): 781296.

    The potential for stiffness value errors when a specific range of image reconstruction parameters is used in combination with Resoundant's algorithm, leading to the reconstruction voxel size settings in the default MRE scan protocol displaying too small.

  • FDAClass II

    LIFEPAK 15

    Some defibrillators serviced between July 2023 through November 2025 were serviced without objective evidence that a Performance Inspection Procedure (PIP) was conducted, and the inability to perform the device's intended use may result in potential harms such as delays or inability to provide therapy.

  • FDAClass II

    LUCAS 2 Model Number: 99576 Catalog Numbers: 99576-000024 and 99576-000011 UDI-DI code: 00883873904565 LUCAS 3

    Due to a subset of chest compression systems/devices where the service performed on the systems were not appropriately documented (The documents for the service performed to justify the passing results were not include in the service records).

  • FDAClass II

    Medtronic Marinr Steerable

    Incomplete seals on sterile product

  • FDAClass II

    Daig Livewire Steerable

    Incomplete seals on sterile product

  • FDAClass II

    Daig Livewire Steerable

    Incomplete seals on sterile product

  • FDAClass II

    Daig Livewire Steerable

    Incomplete seals on sterile product

  • FDAClass II

    Daig Livewire Steerable

    Incomplete seals on sterile product

  • FDAClass II

    Daig Livewire Steerable

    Incomplete seals on sterile product

  • FDAClass II

    Daig Livewire Steerable

    Incomplete seals on sterile product

  • FDAClass II

    Daig Livewire Steerable

    Incomplete seals on sterile product

  • FDAClass II

    Daig Livewire Steerable

    Incomplete seals on sterile product

  • FDAClass II

    Daig Livewire Steerable

    Incomplete seals on sterile product

  • FDAClass II

    Daig Livewire Steerable

    Incomplete seals on sterile product

  • FDAClass II

    Daig Livewire Steerable

    Incomplete seals on sterile product

  • FDAClass II

    Daig Livewire Steerable

    Incomplete seals on sterile product

  • FDAClass II

    Daig Livewire Steerable BDB

    Incomplete seals on sterile product

  • FDAClass II

    CS Uni-Directional w Auto ID

    Incomplete seals on sterile product

  • FDAClass II

    CS Uni-Directional w Auto ID

    Incomplete seals on sterile product

  • FDAClass II

    BW Webster Duo-Decapolar

    Incomplete seals on sterile product

  • FDAClass II

    BARD EP XT Steerable

    Incomplete seals on sterile product

  • FDAClass II

    BARD EP XT Decapolar Steerable

    Incomplete seals on sterile product

  • FDAClass II

    BARD Dynamic XT Steerable

    Incomplete seals on sterile product

  • FDAClass II

    BARD Dynamic XT Steerable

    Incomplete seals on sterile product

  • FDAClass II

    BARD Dynamic XT Deca Steerable

    Incomplete seals on sterile product

  • FDAClass II

    BARD Dynamic Tip Steerable

    Incomplete seals on sterile product

  • FDAClass II

    BARD Dynamic Tip Steerable

    Incomplete seals on sterile product

  • FDAClass II

    BARD Dynamic Tip Steerable

    Incomplete seals on sterile product

  • FDAClass II

    BARD Dynamic Deca Steerable

    Incomplete seals on sterile product

  • FDAClass I

    NextStep Antegrade Chronic Hemodialysis Catheter

    16F dual-valved splittable sheath introducer, the subject of a supplier recall, was included in impacted hemodialysis kits & sets. Sheath introducer may not split as intended, and may result in withdrawal resistance, prolonged procedure time, pain, bleeding, hematoma, tissue injury, vessel wall injury.

  • FDAClass I

    Cannon II Plus Hemodialysis Catheter

    16F dual-valved splittable sheath introducer, the subject of a supplier recall, was included in impacted hemodialysis kits & sets. Sheath introducer may not split as intended, and may result in withdrawal resistance, prolonged procedure time, pain, bleeding, hematoma, tissue injury, vessel wall injury.

  • FDAClass I

    Arrow Edge Hemodialysis Catheterization Product

    16F dual-valved splittable sheath introducer, the subject of a supplier recall, was included in impacted hemodialysis kits & sets. Sheath introducer may not split as intended, and may result in withdrawal resistance, prolonged procedure time, pain, bleeding, hematoma, tissue injury, vessel wall injury.

  • FDAClass I

    Arrow-Clark VectorFlow Antegrade Chronic Hemodialysis Catheter: REF: ACS-15192-VFI

    16F dual-valved splittable sheath introducer, the subject of a supplier recall, was included in impacted hemodialysis kits & sets. Sheath introducer may not split as intended, and may result in withdrawal resistance, prolonged procedure time, pain, bleeding, hematoma, tissue injury, vessel wall injury.

  • FDAClass II

    Medtronic SynchroMed Flex Infusion Mode - A810 Clinician Programmer Software Application

    Software issue: When programming the SynchroMed Pump with the A810 CP App in Flex Infusion Mode, the infusion steps should automatically be arranged in consecutive order, from earliest to latest. However, in rare cases, the steps may be displayed out of order. If this occurs, the programmed Flex Infusion schedule will not be delivered at the intended time, if at all.

  • FDAClass II

    BD GasPak EZ CO2 Pouch System.

    BD identified an issue affecting certain lots of BD GasPak EZ CO2 and BD GasPak EZ Campy Gas Generating Pouch Systems, where gas generating sachets may produce carbon dioxide levels below specification.

  • FDAClass II

    BD GasPak EZ Campy Pouch System.

    BD identified an issue affecting certain lots of BD GasPak EZ CO2 and BD GasPak EZ Campy Gas Generating Pouch Systems, where gas generating sachets may produce carbon dioxide levels below specification.

  • FDAClass II

    LVIS Intraluminal Support Device

    Stent-assisted coiling device may due to commingling during manufacturing have dimensional nonconformance and/or incorrect device configuration. If device is oversized may lead to increased vessel wall stress, neointimal hyperplasia, vessel injury/rupture; if undersized may lead to incomplete expansion/malposition, acute stent thrombosis, distal embolization, ischemic neurological events

  • FDAClass II

    Depuy Synthes, ATTUNE REVISION HINGE FEMORAL RT SZ 8 CEM.

    The external sterile packaging was found adhered to the internal sterile packaging, potentially compromising sterility.

  • FDAClass II

    Depuy Synthes, ATTUNE REVISION HINGE FEMORAL RT SZ 7 CEM.

    The external sterile packaging was found adhered to the internal sterile packaging, potentially compromising sterility.

  • FDAClass II

    Depuy Synthes, ATTUNE REVISION HINGE FEMORAL RT SZ 5 CEM.

    The external sterile packaging was found adhered to the internal sterile packaging, potentially compromising sterility.

  • FDAClass II

    Depuy Synthes, ATTUNE REVISION HINGE FEMORAL RT SZ 4 CEM.

    The external sterile packaging was found adhered to the internal sterile packaging, potentially compromising sterility.

  • FDAClass II

    Depuy Synthes, ATTUNE REVISION HINGE FEMORAL RT SZ 3 CEM.

    The external sterile packaging was found adhered to the internal sterile packaging, potentially compromising sterility.

  • FDAClass II

    Depuy Synthes, ATTUNE REVISION HINGE FEMORAL LT SZ 8 CEM.

    The external sterile packaging was found adhered to the internal sterile packaging, potentially compromising sterility.

  • FDAClass II

    Depuy Synthes, ATTUNE REVISION HINGE FEMORAL LT SZ 7 CEM.

    The external sterile packaging was found adhered to the internal sterile packaging, potentially compromising sterility.

  • FDAClass II

    Depuy Synthes, ATTUNE REVISION HINGE FEMORAL LT SZ 5 CEM.

    The external sterile packaging was found adhered to the internal sterile packaging, potentially compromising sterility.

  • FDAClass II

    Depuy Synthes, ATTUNE REVISION HINGE FEMORAL LT SZ 4 CEM.

    The external sterile packaging was found adhered to the internal sterile packaging, potentially compromising sterility.

  • FDAClass I

    Custom Convenience Kit containing recalled Medline Namic Angiographic Control Syringes with Rotating Adapter (Namic

    Affected kits contain Medline Namic RA Syringes, which are recalled by their manufacturer due to risk of syringe rotating adapter unwinding during use, which may result in a loose connection or full disconnection between syringe and manifold. If unwinding occurs, there is a potential for biohazard exposure, blood loss, infection. or air embolism.

  • FDAClass II

    Philips Bridge Prep Kit REF: K12-09098C Sterile EO

    catheter may experience resistance when being advanced over the guidewire

  • FDAClass II

    Philips Bridge Prep Kit REF: K12-09098C Sterile EO

    catheter may experience resistance when being advanced over the guidewire

  • FDAClass II

    Philips Bridge Prep Kit REF: K12-09098B Sterile EO

    catheter may experience resistance when being advanced over the guidewire

  • FDAClass II

    Uric Acid in vitro diagnostic test REF: 31H0P

    The devices were distributed without required FDA premarket clearance or approval.

  • FDAClass II

    QUCARE Total Cholesterol in vitro diagnostic test REF: 6407

    The devices were distributed without required FDA premarket clearance or approval.

  • FDAClass II

    One Step UTI in vitro diagnostic test REF: 3374

    The devices were distributed without required FDA premarket clearance or approval.

  • FDAClass II

    One Step pH in vitro diagnostic test REF: 31I4P

    The devices were distributed without required FDA premarket clearance or approval.

  • FDAClass II

    One Step P in vitro diagnostic test REF: 8194

    The devices were distributed without required FDA premarket clearance or approval.

  • FDAClass II

    One Step K in vitro diagnostic test REF: 81A4

    The devices were distributed without required FDA premarket clearance or approval.

  • FDAClass II

    One Step 10A in vitro diagnostic test

    The devices were distributed without required FDA premarket clearance or approval.

  • FDAClass I

    Centimeter Sizing Catheter RPN N5.0-35-100-P-10S-PIG-CSC-20 GPN G11916 Catheters for use in angiographic

    Marker bands may be at an increased risk of cracking/breakage. Potential adverse events that may result include increased procedural time, harms associated with device fragmentation/separation, and vessel injury. In a worst-case scenario, device fragmentation and separation may cause life-threatening harm or death.

  • FDAClass I

    Beacon Tip Centimeter Sizing Catheter RPN/GPN NR5.0-35-70-P-10S-0-CSC-20 G31213 NR5.0-35-100-P-10S-0-CSC-20

    Marker bands may be at an increased risk of cracking/breakage. Potential adverse events that may result include increased procedural time, harms associated with device fragmentation/separation, and vessel injury. In a worst-case scenario, device fragmentation and separation may cause life-threatening harm or death.

  • FDAClass I

    Aurous Centimeter Sizing Catheter RPN N5.0-35-100-P-10S-PIG-CSC-20-01 GPN G47308 Sizing catheters are single-use

    Marker bands may be at an increased risk of cracking/breakage. Potential adverse events that may result include increased procedural time, harms associated with device fragmentation/separation, and vessel injury. In a worst-case scenario, device fragmentation and separation may cause life-threatening harm or death.

  • FDAClass II

    i-STAT G3+ cartridge

    Approximately 7.6% of cartridges from specific i-STAT EG7+ (list number 03P76-25), i-STAT EG6+ (list number 03P77-25) and i-STAT G3+ (list number 03P78-26) cartridge lots in the U.S. marketplace may report higher than expected PCO2 and lower than expected pH results due to a manufacturing issue. A falsely high pCO2 together with a falsely low pH makes the blood gas appear as if the patient is in severe respiratory acidosis. If the clinician believes the values are real, it may trigger unnecessary or even harmful interventions such as unnecessary ventilator changes, unnecessary medications, potential harm from overcorrection, or delays in identifying true problems.

  • FDAClass II

    i-STAT EG7+ cartridge

    Approximately 7.6% of cartridges from specific i-STAT EG7+ (list number 03P76-25), i-STAT EG6+ (list number 03P77-25) and i-STAT G3+ (list number 03P78-26) cartridge lots in the U.S. marketplace may report higher than expected PCO2 and lower than expected pH results due to a manufacturing issue. A falsely high pCO2 together with a falsely low pH makes the blood gas appear as if the patient is in severe respiratory acidosis. If the clinician believes the values are real, it may trigger unnecessary or even harmful interventions such as unnecessary ventilator changes, unnecessary medications, potential harm from overcorrection, or delays in identifying true problems.

  • FDAClass II

    i-STAT EG6+ cartridge

    Approximately 7.6% of cartridges from specific i-STAT EG7+ (list number 03P76-25), i-STAT EG6+ (list number 03P77-25) and i-STAT G3+ (list number 03P78-26) cartridge lots in the U.S. marketplace may report higher than expected PCO2 and lower than expected pH results due to a manufacturing issue. A falsely high pCO2 together with a falsely low pH makes the blood gas appear as if the patient is in severe respiratory acidosis. If the clinician believes the values are real, it may trigger unnecessary or even harmful interventions such as unnecessary ventilator changes, unnecessary medications, potential harm from overcorrection, or delays in identifying true problems.

  • FDAClass II

    ERBEFLO CleverCap: Hybrid Tubing/Cap Set for Olympus Scopes

    Devices providing sterile water/CO2/air to endoscopes were manufactured with a distal irrigation segment connector configuration that may be more susceptible to unintended water flow from distal tip under unsupported third-party connector use conditions, which may lead to water aspiration, which may progress to aspiration pneumonia, acute respiratory distress syndrome, or respiratory failure.

  • FDAClass II

    ERBEFLO CleverCap CO2: Hybrid CO2 Tubing/Cap Set for Olympus Scopes & CO2 Sources

    Devices providing sterile water/CO2/air to endoscopes were manufactured with a distal irrigation segment connector configuration that may be more susceptible to unintended water flow from distal tip under unsupported third-party connector use conditions, which may lead to water aspiration, which may progress to aspiration pneumonia, acute respiratory distress syndrome, or respiratory failure.

  • FDAClass II

    ERBEFLO 2

    Devices providing sterile water/CO2/air to endoscopes were manufactured with a distal irrigation segment connector configuration that may be more susceptible to unintended water flow from distal tip under unsupported third-party connector use conditions, which may lead to water aspiration, which may progress to aspiration pneumonia, acute respiratory distress syndrome, or respiratory failure.

  • FDAClass II

    Brand Name: Disposable Mixing Bowls with Spatula Product Name: Mixing Bowl and Spatula Model/Catalog Number:

    Ten complaints have been received identifying issues at the time of use related to the package seal, including incomplete seals, wrinkles in the seals or peeling seals. Compromised sterile barrier may lead to clinically insignificant extension of surgery or infection leading to surgical intervention.

  • FDAClass II

    LUX-Dx II Plus

    For some patients upgraded from a LUX-Dx M301 device to a new Model M302 or M312, the new ICM device is not collecting PVC Burden data (both M302/M312) or monitoring for Bradyarrhythmia and Pause (M312 only). In addition, for these devices that are not being monitored, the LATITUDE Clarity programming screens have discrepant information, indicating that the monitoring is enabled for these features in one location and not enabled in another location.

  • FDAClass II

    LUX-DX II

    For some patients upgraded from a LUX-Dx M301 device to a new Model M302 or M312, the new ICM device is not collecting PVC Burden data (both M302/M312) or monitoring for Bradyarrhythmia and Pause (M312 only). In addition, for these devices that are not being monitored, the LATITUDE Clarity programming screens have discrepant information, indicating that the monitoring is enabled for these features in one location and not enabled in another location.

  • FDAClass I

    AIDBAGs are first aid kits of convenience composed of individually labeled devices designed as specialty first aid

    Kits contain the McKesson TRUE Metrix PRO Professional Monitoring Blood Glucose System that has been recalled for an issue with the software design of the E-5 Error Code where the meter displays an E-5 error code for a very high blood glucose event (> 600 mg/dL) or when there is a test strip error, which can lead to operator confusion when evaluating patients and a delay in appropriate treatment. This is a downstream recall of Trividia Health Class I, Recall Event ID 98317.

  • FDAClass II

    Rover Mobile X-ray System Model/Catalog Number: MXU-RV35 and MXU-RV71

    X-Ray generator may malfunction resulting in the X-Ray being inoperable.

  • FDAClass II

    Edwards EVOQUE tricuspid delivery system REF:9850TDS Sterile EO

    Labeling update to provide warning if functionality of the valve replacement delivery system is compromised.

  • FDAClass II

    Brand Name: Spacelabs Ultraview SL Command Module Product Name: SL Command Module Model/Catalog Number: 91496

    Due to a manufacturing issue (i.e. malfunctioning of electrical Leakage tester).

  • FDAClass II

    ZENBONE

    Resorbable bone void filler falls outside standard specifications.

  • FDAClass II

    BioCera Fibers

    Resorbable bone void filler falls outside standard specifications.

  • FDAClass I

    Rolls of label stock used with the Omnicell i.v.Station. 1. Part Number 258920028

    Potential for mislabeled syringe produced by the i.v.STATION device.

  • FDAClass II

    OER-ELITE Endoscope Reprocessor Connecting Tubes.

    Potential for the Version 2 reprocessor connecting tube lock levers may fail prematurely.

  • FDAClass II

    OER-ELITE Endoscope Reprocessor Connecting Tubes.

    Potential for the Version 2 reprocessor connecting tube lock levers may fail prematurely.

  • FDAClass II

    OER-ELITE Endoscope Reprocessor Connecting Tubes.

    Potential for the Version 2 reprocessor connecting tube lock levers may fail prematurely.

  • FDAClass II

    OER-ELITE Endoscope Reprocessor Connecting Tubes.

    Potential for the Version 2 reprocessor connecting tube lock levers may fail prematurely.

  • FDAClass II

    OER-ELITE Endoscope Reprocessor Connecting Tubes.

    Potential for the Version 2 reprocessor connecting tube lock levers may fail prematurely.

  • FDAClass II

    OER-ELITE Endoscope Reprocessor Connecting Tubes.

    Potential for the Version 2 reprocessor connecting tube lock levers may fail prematurely.

  • FDAClass II

    OER-ELITE Endoscope Reprocessor Connecting Tubes.

    XXX

  • FDAClass II

    OER-ELITE Endoscope Reprocessor Connecting Tubes.

    Potential for the Version 2 reprocessor connecting tube lock levers may fail prematurely.

  • FDAClass II

    OER-ELITE Endoscope Reprocessor Connecting Tubes.

    Potential for the Version 2 reprocessor connecting tube lock levers may fail prematurely.

  • FDAClass II

    OER-ELITE Endoscope Reprocessor Connecting Tubes.

    Potential for the Version 2 reprocessor connecting tube lock levers may fail prematurely.

  • FDAClass II

    OER-ELITE Endoscope Reprocessor Connecting Tubes.

    Potential for the Version 2 reprocessor connecting tube lock levers may fail prematurely.

  • FDAClass II

    OER-ELITE Endoscope Reprocessor Connecting Tubes.

    Potential for the Version 2 reprocessor connecting tube lock levers may fail prematurely.

  • FDAClass II

    DEX Ophthalmic Tissue Forceps

    Ophthalmic Tissue Forceps (DEX") are sterile, hand-held ophthalmic surgical instruments designed for grasping, manipulating, compressing, pulling, or joining eye and/or surrounding tissues during surgical procedures. These devices fall under the GMDN code 62478 entitled Ophthalmic soft-tissue surgical forceps, probe-like, single use . Double pouched in tyvek pouches, sold in boxes of 5 with an inner and outer box.

  • FDAClass II

    DEX Ophthalmic Tissue Forceps

    Field Safety Corrective Action for IFU in DEX Forceps and Scissors.

  • FDAClass II

    DEX Ophthalmic Tissue Forceps

    Field Safety Corrective Action for IFU in DEX Forceps and Scissors.

  • FDAClass II

    DEX Ophthalmic Tissue Forceps

    Field Safety Corrective Action for IFU in DEX Forceps and Scissors.

  • FDAClass II

    DEX Ophthalmic Tissue Forceps

    Field Safety Corrective Action for IFU in DEX Forceps and Scissors.

  • FDAClass II

    DEX Ophthalmic Tissue Forceps

    Field Safety Corrective Action for IFU in DEX Forceps and Scissors.

  • FDAClass II

    DEX Ophthalmic Tissue Forceps

    Field Safety Corrective Action for IFU in DEX Forceps and Scissors.

  • FDAClass II

    DEX Ophthalmic Tissue Forceps

    Field Safety Corrective Action for IFU in DEX Forceps and Scissors.

  • FDAClass II

    DEX Ophthalmic Tissue Forceps

    Field Safety Corrective Action for IFU in DEX Forceps and Scissors.

  • FDAClass II

    DEX Ophthalmic Tissue Forceps

    Field Safety Corrective Action for IFU in DEX Forceps and Scissors.

  • FDAClass II

    DEX Ophthalmic Tissue Forceps

    Field Safety Corrective Action for IFU in DEX Forceps and Scissors.

  • FDAClass II

    DEX Ophthalmic Tissue Forceps

    Field Safety Corrective Action for IFU in DEX Forceps and Scissors.

  • FDAClass III

    Heraeus, PALAMIX duo.

    Based on long-term stability testing, it was determined that in units older than 1.5 years (17 months) the mixing rod may, in rare cases, come loose from its lock during the mixing process. Notification is to reduce the shelf life from 3 years to 1.5 years (17 months).

  • FDAClass III

    Heraeus, PALAMIX uno.

    Based on long-term stability testing, it was determined that in units older than 1.5 years (17 months) the mixing rod may, in rare cases, come loose from its lock during the mixing process. Notification is to reduce the shelf life from 3 years to 1.5 years (17 months).

  • FDAClass II

    Olympus Thunderbeat II Shears w/Ultrasonic Mode, 5mm, 45cm.

    Potential for detachment of a distal tip component of the device during use.

  • FDAClass II

    Olympus Thunderbeat II Shears w/Ultrasonic Mode, 5mm, 35cm.

    Potential for detachment of a distal tip component of the device during use.

  • FDAClass II

    Olympus Thunderbeat II Shears w/Ultrasonic Mode, 5mm, 25cm.

    Potential for detachment of a distal tip component of the device during use.

  • FDAClass II

    Olympus Thunderbeat II Shears w/Ultrasonic Mode, 5mm, 20cm.

    Potential for detachment of a distal tip component of the device during use.

  • FDAClass II

    Brand Name: Genius" Review Station Product Name: Genius" Review Station Display (Barco Monitor) Model/Catalog

    It was identified that certain devices were being operated outside the validated and FDA-cleared display configuration due to user modification of the manufacturer-installed settings. Modifications included disabling Barco Application Appearance Manager (AAM), altering calibration and compliance parameters, and adjusting additional display-related settings. This field correction is being conducted to restore affected system to the validated configuration and reinforce proper use in accordance with the Operator's Manual.

  • FDAClass II

    Gentuity HF-OCT Imaging System Model G10-01

    The potential for repeated frames during HF-OCT pullback when using the Gentuity HF-OCT Console (software version 21.11 to 23.3.13) with the Vis-Rx and Vis-Rx Prime catheters. This correction is intended to ensure that users are fully informed of how to recognize, avoid, and mitigate this condition to maintain accurate longitudinal (length) measurements during OCT imaging.

  • FDAClass II

    Prodisc C SK U.S. IMPLANT EXTRA LARGE 6MM. Model Number: PDSXL6. Total cervical disc replacement.

    Product labeling mix up. The prodisc C SK U.S. Implant Extra Large 6mm product was labeled as a 5mm and prodisc C SK U.S. Implant Extra Large 5mm product was labeled as a 6mm.

  • FDAClass II

    Prodisc C SK U.S. IMPLANT EXTRA LARGE 5MM. Model: PDSXL5 Total cervical disc replacement.

    Product labeling mix up. The prodisc C SK U.S. Implant Extra Large 6mm product was labeled as a 5mm and prodisc C SK U.S. Implant Extra Large 5mm product was labeled as a 6mm.

  • FDAClass II

    Brand Name: DONJOY Product Name: ICEMAN W/

    Due to broken connector which may result in a temporary interruption of prescribed cold therapy.

  • FDAClass II

    Brand Name: DONJOY Product Name: ICEMAN W/

    Due to broken connector which may result in a temporary interruption of prescribed cold therapy.

  • FDAClass II

    Brand Name: DONJOY Product Name: ICEMAN

    Due to broken connector which may result in a temporary interruption of prescribed cold therapy.

  • FDAClass II

    Brand Name: DONJOY Product Name: ICEMAN CLASSIC CUBE Model/Catalog Number: 11-0494 Software Version: no Product

    Due to broken connector which may result in a temporary interruption of prescribed cold therapy.

  • FDAClass I

    Boston Scientific Pacemaker

    Updated software, Brady software maintenance release 6 (SMR6), is now available for the ACCOLADE" family of pacemakers and cardiac resynchronization therapy pacemakers (CRT-Ps)1 and the advisory population is expanding to include all CRT-P and dual-chamber extended life (DR-EL) devices. Dual chamber modes are specifically indicated for treatment of the following: " Conduction disorders that require restoration of AV synchrony, including varying degrees of AV block " VVI intolerance (i.e., pacemaker syndrome) in the presence of persistent sinus rhythm " Low cardiac output or congestive heart failure secondary to bradycardia

  • FDAClass I

    Boston Scientific Cardiac Resynchronization Therapy (CRT)labeled as: 1.

    Updated software, Brady software maintenance release 6 (SMR6), is now available for the ACCOLADE" family of pacemakers and cardiac resynchronization therapy pacemakers (CRT-Ps)1 and the advisory population is expanding to include all CRT-P and dual-chamber extended life (DR-EL) devices. Dual chamber modes are specifically indicated for treatment of the following: " Conduction disorders that require restoration of AV synchrony, including varying degrees of AV block " VVI intolerance (i.e., pacemaker syndrome) in the presence of persistent sinus rhythm " Low cardiac output or congestive heart failure secondary to bradycardia

  • FDAClass I

    B.

    Potential for the accumulation of small air bubbles in the arterial line due to adherence of blood gases to the tubing under negative pressure.

  • FDAClass I

    B.

    Potential for the accumulation of small air bubbles in the arterial line due to adherence of blood gases to the tubing under negative pressure.

  • FDAClass I

    B.

    Potential for the accumulation of small air bubbles in the arterial line due to adherence of blood gases to the tubing under negative pressure.

  • FDAClass I

    B.

    Potential for the accumulation of small air bubbles in the arterial line due to adherence of blood gases to the tubing under negative pressure.

  • FDAClass I

    B.

    Potential for the accumulation of small air bubbles in the arterial line due to adherence of blood gases to the tubing under negative pressure.

  • FDAClass I

    B Braun Hemodialysis Bloodlines

    Potential for the accumulation of small air bubbles in the arterial line due to adherence of blood gases to the tubing under negative pressure.

  • FDAClass I

    Convenience kits containing Medline Namic Angiographic Control Syringes with Rotating Adaptor CORONARY ANGIO PACK

    Impacted kits contain syringes recalled by Medline Industries. Syringe rotating adaptor may unwind during use, which may result in a loose connection or full disconnection between the syringe and manifold. Potential risk for biohazard exposure, blood loss, infection, or air embolism.

  • FDAClass II

    Diversatek Healthcare Viper¿ 3-Stage Wire Guided Balloon Dilator

    The catheter inflation tag attached to the device may contain an incorrect part number with incorrect balloon diameter sizes and inflation pressures for each stage.

  • FDAClass II

    Diversatek Healthcare Viper¿ 3-Stage Wire Guided Balloon Dilator

    The catheter inflation tag attached to the device may contain an incorrect part number with incorrect balloon diameter sizes and inflation pressures for each stage.

  • FDAClass II

    Diversatek Healthcare Viper¿ 3-Stage Wire Guided Balloon Dilator

    The catheter inflation tag attached to the device may contain an incorrect part number with incorrect balloon diameter sizes and inflation pressures for each stage.

  • FDAClass II

    Diversatek Healthcare Viper¿ 3-Stage Fixed Wire Balloon Dilator

    The catheter inflation tag attached to the device may contain an incorrect part number with incorrect balloon diameter sizes and inflation pressures for each stage.

  • FDAClass I

    Medical Action Industries Inc.

    Convenience kit contains a syringe in which the rotating adapter may unwind during use, resulting in a loose connection and/or full disconnection between the syringe and manifold"

  • FDAClass II

    Flamingo Funnel Small

    Certain lots of product were associated with a manufacturing nonconformance involving use of a non-gamma sterilization compatible drape.

  • FDAClass II

    Flamingo Funnel Medium

    Certain lots of product were associated with a manufacturing nonconformance involving use of a non-gamma sterilization compatible drape.

  • FDAClass II

    Flamingo Funnel Large

    Certain lots of product were associated with a manufacturing nonconformance involving use of a non-gamma sterilization compatible drape.

  • FDAClass II

    Medline or Centurion medical convenience kits, containing Webcol Large Alcohol Prep Pads, labeled as: 1.

    Medline Industries, LP is issuing a recall for specific item(s) and lot(s) of Medline Kits containing Cardinal Health Webcol Large Alcohol Prep Pads. Cardinal Health has deemed Webcol Large Alcohol Prep Pads to be non-sterile following the discovery of a contaminant (Paenibacillus phoenicis) during a routine sterilization dose audit.

  • FDAClass II

    Medline medical convenience kits, containing Webcol Large Alcohol Prep Pads, labeled as: 1.

    Medline Industries, LP is issuing a recall for specific item(s) and lot(s) of Medline Kits containing Cardinal Health Webcol Large Alcohol Prep Pads. Cardinal Health has deemed Webcol Large Alcohol Prep Pads to be non-sterile following the discovery of a contaminant (Paenibacillus phoenicis) during a routine sterilization dose audit.

  • FDAClass II

    Medline and Centurion medical convenience kits, containing Webcol Large Alcohol Prep Pads, labeled as: 1.

    Medline Industries, LP is issuing a recall for specific item(s) and lot(s) of Medline Kits containing Cardinal Health Webcol Large Alcohol Prep Pads. Cardinal Health has deemed Webcol Large Alcohol Prep Pads to be non-sterile following the discovery of a contaminant (Paenibacillus phoenicis) during a routine sterilization dose audit.

  • FDAClass II

    Medline and Centurion medical convenience kits, containing Webcol Large Alcohol Prep Pads, labeled as: 1.

    Medline Industries, LP is issuing a recall for specific item(s) and lot(s) of Medline Kits containing Cardinal Health Webcol Large Alcohol Prep Pads. Cardinal Health has deemed Webcol Large Alcohol Prep Pads to be non-sterile following the discovery of a contaminant (Paenibacillus phoenicis) during a routine sterilization dose audit.

  • FDAClass II

    Centurion medical convenience kits

    Medline Industries, LP is issuing a recall for specific item(s) and lot(s) of Medline Kits containing Cardinal Health Webcol Large Alcohol Prep Pads. Cardinal Health has deemed Webcol Large Alcohol Prep Pads to be non-sterile following the discovery of a contaminant (Paenibacillus phoenicis) during a routine sterilization dose audit.

  • FDAClass II

    Centurion medical convenience kits

    Medline Industries, LP is issuing a recall for specific item(s) and lot(s) of Medline Kits containing Cardinal Health Webcol Large Alcohol Prep Pads. Cardinal Health has deemed Webcol Large Alcohol Prep Pads to be non-sterile following the discovery of a contaminant (Paenibacillus phoenicis) during a routine sterilization dose audit.

  • FDAClass II

    Centurion medical convenience kits

    Medline Industries, LP is issuing a recall for specific item(s) and lot(s) of Medline Kits containing Cardinal Health Webcol Large Alcohol Prep Pads. Cardinal Health has deemed Webcol Large Alcohol Prep Pads to be non-sterile following the discovery of a contaminant (Paenibacillus phoenicis) during a routine sterilization dose audit.

  • FDAClass II

    CENTURION Circumcision Kit

    On lot of Sterile Circumcision Kits was distributed without the required sterilization process and is therefore not sterile.

  • FDAClass II

    Access Total T4 Calibrator, Catalog No.

    Beckman Coulter has identified that Access Total T4 Calibrator lots (PN 33805) exhibit a negative bias on DxI 600/800 instruments, with slopes outside product specifications. A false low patient result could cause a patient to undergo unnecessary additional diagnostic testing. A patient may be treated for a disorder not present or receive delayed treatment for hyperthyroidism. For a pregnant patient being monitored for thyroid hormone supplementation, incorrect treatment or dose may be used. A delayed patient results could cause repeat blood draw with associated complications.

  • FDAClass II

    LeadCare Ultra Blood Lead Test Kit

    Customers reported observing unexpectedly elevated results when using certain third-party micro-collection devices to collect capillary samples for testing with the LeadCare Test Systems. False positive lead results may cause delayed results and additional unnecessary testing.

  • FDAClass II

    LeadCare¿ Plus Blood Lead Test Kit

    Customers reported observing unexpectedly elevated results when using certain third-party micro-collection devices to collect capillary samples for testing with the LeadCare Test Systems. False positive lead results may cause delayed results and additional unnecessary testing.

  • FDAClass II

    (1)(2) LeadCare¿ II Blood Lead Test Kit

    Customers reported observing unexpectedly elevated results when using certain third-party micro-collection devices to collect capillary samples for testing with the LeadCare Test Systems. False positive lead results may cause delayed results and additional unnecessary testing.

  • FDAClass I

    Halyard VA DETROIT CATH LAB PACK kit.

    Potential risk for Medline syringe rotating adaptor unwinding during use, which may result in a loose connection and/or full disconnection between the syringe and manifold.

  • FDAClass I

    Halyard SAMMC ANGIOGRAPHY kit.

    Potential risk for Medline syringe rotating adaptor unwinding during use, which may result in a loose connection and/or full disconnection between the syringe and manifold.

  • FDAClass I

    Halyard PERC TRAY kit.

    Potential risk for Medline syringe rotating adaptor unwinding during use, which may result in a loose connection and/or full disconnection between the syringe and manifold.

  • FDAClass I

    Halyard NEURO IR PERIPHERAL (PS 64405) kit.

    Potential risk for Medline syringe rotating adaptor unwinding during use, which may result in a loose connection and/or full disconnection between the syringe and manifold.

  • FDAClass I

    Halyard HEART CATH, SELF REGIONAL kit.

    Potential risk for Medline syringe rotating adaptor unwinding during use, which may result in a loose connection and/or full disconnection between the syringe and manifold.

  • FDAClass I

    Halyard CATH LAB kit.

    Potential risk for Medline syringe rotating adaptor unwinding during use, which may result in a loose connection and/or full disconnection between the syringe and manifold.

  • FDAClass I

    Halyard CATH LAB kit.

    Potential risk for Medline syringe rotating adaptor unwinding during use, which may result in a loose connection and/or full disconnection between the syringe and manifold.

  • FDAClass I

    Halyard CARDIAC CATH TRAY SHANDS JAX kit.

    Potential risk for Medline syringe rotating adaptor unwinding during use, which may result in a loose connection and/or full disconnection between the syringe and manifold.

  • FDAClass I

    Halyard CARDIAC CATH PACK SAN23CARDQ kit.

    Potential risk for Medline syringe rotating adaptor unwinding during use, which may result in a loose connection and/or full disconnection between the syringe and manifold.

  • FDAClass I

    Halyard CARDIAC CATH PACK kit.

    Potential risk for Medline syringe rotating adaptor unwinding during use, which may result in a loose connection and/or full disconnection between the syringe and manifold.

  • FDAClass II

    ARTIS Pheno VE30A and VE40A

    During 3D acquisitions, lighter and darker patient images may be captured, which may result in less accurate 3D reconstruction. The variation of brightness is a result of a constant unregulated medium dose and the angular change of patient diameter caused by rotational acquisition. This may result in unintentional low-dose radiation exposure to a patient.

  • FDAClass I

    Omnipod 5 Pods.

    Due to a manufacturing defect, certain Omnipod 5 Pods from 49 lots have an internal soft cannula tear that results in insulin leaking into the Pod instead of being delivered to the user regardless of basal or bolus delivery. This defect results from damage to the unexposed portion of the soft cannula during manufacturing, which would result in a compromised fluid path. The primary failure mode is pump under-delivery due to loss of insulin to an internal leak; in some cases, the defect may also lead to pump shutoff and cessation of insulin delivery when leaked insulin contacts Pod circuity in a manner that results in an electrical short. Under-delivery of insulin (both basal and bolus insulin) or cessation of insulin put users at risk of hyperglycemia, and complications from acute and chronic hyperglycemia, including dehydration, blurry vision, nausea, vomiting, altered mental status, diabetic ketoacidosis (DKA), hyperglycemic hyperosmolar syndrome (HHS), or even death. Users may require hospitalization or medical intervention to treat severe adverse health consequences. Not all devices with the defect will issue an alarm or alert the user. If there is sufficient leakage of insulin to cause a short in the circuity, the Pod will issue a Hazard Alarm that stops all insulin delivery and alerts the user to replace their Pod. In addition, if a user s glucose is trending high and is not responding to insulin delivery, the system may reach the maximum amount of insulin microboluses allowed by the system and trigger the Automated Delivery Restriction (ADR) alert that tells users to check their blood glucose and take appropriate actions (i.e., ADR is a response to persistent hyperglycemia and maximum automated delivery constraints rather than a direct detection of the leak). The magnitude of under-delivery is unknown and based on multiple factors, including how much insulin is being delivered, whether an alarm and/or alert triggers, whether and when the user recognizes the device defect, the duration of Pod use, and the size of the tear.

  • FDAClass II

    Mesh Style Tip Protectors CSW-03-2.0 Open-end style CSW-04-4.0 Closed-end style

    Product does not have FDA clearance.

  • FDAClass II

    Custom Convenience Kits Pre Op Kit - NS

    The product correction was initiated because B Braun is issuing a voluntary Urgent Medical Device Correction for gravity IV administration sets as well as pump administration sets utilized with BBMI s Infusomat Space Large Volume Pump, Outlook Pump and Vista Basic Pump due to potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers or other connections and the ability to prime (occlusion).

  • FDAClass II

    Custom Convenience Kits Pre Op Kit - NS

    The product correction was initiated because B Braun is issuing a voluntary Urgent Medical Device Correction for gravity IV administration sets as well as pump administration sets utilized with BBMI s Infusomat Space Large Volume Pump, Outlook Pump and Vista Basic Pump due to potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers or other connections and the ability to prime (occlusion).

  • FDAClass II

    Custom Convenience Kits Pre Op Kit - NS

    The product correction was initiated because B Braun is issuing a voluntary Urgent Medical Device Correction for gravity IV administration sets as well as pump administration sets utilized with BBMI s Infusomat Space Large Volume Pump, Outlook Pump and Vista Basic Pump due to potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers or other connections and the ability to prime (occlusion).

  • FDAClass II

    Medtronic Sphere-9 Catheter

    ventricular fibrillation (VF) during radiofrequency (RF) therapy with the Medtronic Sphere-9 catheter in patients who have a Biotronik Implantable Cardioverter Defibrillator (ICD) or Biotronik Cardiac Resynchronization Therapy-Defibrillator (CRT-D) implanted. The observation is caused by an interaction between the Sphere-9 catheter current flow and a safety feature built into Biotronik ICDs and CRT Ds. Medtronic recommends physicians use increased caution when using the Sphere-9 catheter for RF ablation therapy in patients implanted with a Biotronik ICD/CRT-D system, and to ensure external defibrillation systems are readily available.

  • FDAClass II

    Pressure Injectable Arrowg+ard Blue Plus¿ Four-Lumen CVC Kit REF ASK-45854-PUPM1 UDI code:

    Due to receiving a notice from a supplier that the liquid adhesive was incorrectly manufactured

  • FDAClass II

    PERCUTANEOUS SHEATH INTRODUCER with 7.5 - 8 Fr. Catheter REF ASK-09903-MGH3 UDI code:

    Due to receiving a notice from a supplier that the liquid adhesive was incorrectly manufactured

  • FDAClass II

    MAC" Two-Lumen Central Venous Access Kit for use with 7.5 - 8 Fr. Catheters REF ASK-11142-LC2 UDI code:

    Due to receiving a notice from a supplier that the liquid adhesive was incorrectly manufactured

  • FDAClass II

    FLEXTIP PLUS EPIDURAL CATHETER

    Due to receiving a notice from a supplier that the liquid adhesive was incorrectly manufactured

  • FDAClass II

    Arrowg+ard Blue¿ MAC" Two-Lumen Central Venous Access Kit for use with 7.5 - 8 Fr. Catheters REF ASK-21142-DMC UDI

    Due to receiving a notice from a supplier that the liquid adhesive was incorrectly manufactured

  • FDAClass II

    ARROW RADIAL ARTERY CATHETERIZATION KIT REF ASK-04220-UCL1 UDI code:

    Due to receiving a notice from a supplier that the liquid adhesive was incorrectly manufactured

  • FDAClass II

    ARROW

    Due to receiving a notice from a supplier that the liquid adhesive was incorrectly manufactured

  • FDAClass II

    Arrow Echogenic Introducer Needle REF ASK-04001-BWK2 UDI code: (01)10801902220315(17)261231(11)251210(10)33F25J0347

    Due to receiving a notice from a supplier that the liquid adhesive were incorrectly manufactured

  • FDAClass II

    LSL Healthcare Wound Closure Tray

    Medical procedure kits were distributed containing Webcol Large Alcohol Prep Pads which were subsequently recalled for non-sterility.

  • FDAClass II

    LSL Healthcare

    Medical procedure kits were distributed containing Webcol Large Alcohol Prep Pads which were subsequently recalled for non-sterility.

  • FDAClass II

    LSL Healthcare

    Medical procedure kits were distributed containing Webcol Large Alcohol Prep Pads which were subsequently recalled for non-sterility.

  • FDAClass II

    LSL Healthcare

    Medical procedure kits were distributed containing Webcol Large Alcohol Prep Pads which were subsequently recalled for non-sterility.

  • FDAClass II

    LSL Healthcare

    Medical procedure kits were distributed containing Webcol Large Alcohol Prep Pads which were subsequently recalled for non-sterility.

  • FDAClass II

    LSL Healthcare

    Medical procedure kits were distributed containing Webcol Large Alcohol Prep Pads which were subsequently recalled for non-sterility.

  • FDAClass II

    Brand Name: Kiwi Omni Vacuum Delivery System Product Name: Kiwi Omni Vacuum Delivery System Model/Catalog Number:

    Due to complaints of device breakage at the traction force gauge to handle joint.

  • FDAClass II

    Philips Spectral CT on Rails.

    Philips has identified three software issues: 1. During a continuous CT (CCT) scan, there is the potential that the Gantry could remain at the current scan position after pressing Go. 2. Potential where the message of Previous Surview Exists Select Previous Surview? <Yes> or <No> should display but does not appear. 3. After performing Surview and planning the Brain Helical acquisition by setting Brain Area DoseRight Index to increase the dose, there is the potential that the Define Head Area option in the context menu is grayed out.

  • FDAClass II

    COOK MEDICAL Arterial Pressure Monitoring Tray

    Products from the affected device lots were labeled with expiration dates that exceed the true shelf life.

  • FDAClass II

    Instinct Plus Endoscopic Clipping Device REF: G58010 Rx Only

    Due to increased in complaints their is the potential for endoscopic clipping device to malfunction.

  • FDAClass II

    Soft-Vu Angiographic Catheter

    The affected devices contain a manufacturing defect which may prevent the appropriately sized guidewire from passing through the inner diameter (ID) of the catheter hub.

  • FDAClass II

    Soft-Vu Angiographic Catheter

    The affected devices contain a manufacturing defect which may prevent the appropriately sized guidewire from passing through the inner diameter (ID) of the catheter hub.

  • FDAClass II

    Soft-Vu Angiographic Catheter

    The affected devices contain a manufacturing defect which may prevent the appropriately sized guidewire from passing through the inner diameter (ID) of the catheter hub.

  • FDAClass II

    Soft-Vu Angiographic Catheter

    The affected devices contain a manufacturing defect which may prevent the appropriately sized guidewire from passing through the inner diameter (ID) of the catheter hub.

  • FDAClass II

    Soft-Vu Angiographic Catheter

    The affected devices contain a manufacturing defect which may prevent the appropriately sized guidewire from passing through the inner diameter (ID) of the catheter hub.

  • FDAClass II

    Soft-Vu Angiographic Catheter

    The affected devices contain a manufacturing defect which may prevent the appropriately sized guidewire from passing through the inner diameter (ID) of the catheter hub.

  • FDAClass II

    Soft-Vu Angiographic Catheter

    The affected devices contain a manufacturing defect which may prevent the appropriately sized guidewire from passing through the inner diameter (ID) of the catheter hub.

  • FDAClass II

    Soft-Vu Angiographic Catheter

    The affected devices contain a manufacturing defect which may prevent the appropriately sized guidewire from passing through the inner diameter (ID) of the catheter hub.

  • FDAClass II

    Soft-Vu Angiographic Catheter

    The affected devices contain a manufacturing defect which may prevent the appropriately sized guidewire from passing through the inner diameter (ID) of the catheter hub.

  • FDAClass II

    Soft-Vu Angiographic Catheter

    The affected devices contain a manufacturing defect which may prevent the appropriately sized guidewire from passing through the inner diameter (ID) of the catheter hub.

  • FDAClass II

    Soft-Vu Angiographic Catheter

    The affected devices contain a manufacturing defect which may prevent the appropriately sized guidewire from passing through the inner diameter (ID) of the catheter hub.

  • FDAClass II

    Soft-Vu Angiographic Catheter

    The affected devices contain a manufacturing defect which may prevent the appropriately sized guidewire from passing through the inner diameter (ID) of the catheter hub.

  • FDAClass II

    Soft-Vu Angiographic Catheter

    The affected devices contain a manufacturing defect which may prevent the appropriately sized guidewire from passing through the inner diameter (ID) of the catheter hub.

  • FDAClass II

    Soft-Vu Angiographic Catheter

    The affected devices contain a manufacturing defect which may prevent the appropriately sized guidewire from passing through the inner diameter (ID) of the catheter hub.

  • FDAClass II

    Soft -Vu Angiographic Catheter

    The affected devices contain a manufacturing defect which may prevent the appropriately sized guidewire from passing through the inner diameter (ID) of the catheter hub.

  • FDAClass II

    Soft-Vu Angiographic Catheter

    The affected devices contain a manufacturing defect which may prevent the appropriately sized guidewire from passing through the inner diameter (ID) of the catheter hub.

  • FDAClass II

    AccuVu Angiographic Catheter

    The affected devices contain a manufacturing defect which may prevent the appropriately sized guidewire from passing through the inner diameter (ID) of the catheter hub.

  • FDAClass II

    AccuVu Angiographic Catheter

    The affected devices contain a manufacturing defect which may prevent the appropriately sized guidewire from passing through the inner diameter (ID) of the catheter hub.

  • FDAClass II

    AccuVu Angiographic Catheter

    The affected devices contain a manufacturing defect which may prevent the appropriately sized guidewire from passing through the inner diameter (ID) of the catheter hub.

  • FDAClass II

    AccuVu Angiographic Catheter

    The affected devices contain a manufacturing defect which may prevent the appropriately sized guidewire from passing through the inner diameter (ID) of the catheter hub.

  • FDAClass I

    NAMIC Angiographic Control Syringe, labeled as follows: 1.

    Medline Industries, LP has identified through post-market surveillance a potential risk of the syringe rotating adaptor unwinding during use, which may result in a loose connection and/or full disconnection between the syringe and manifold.

  • FDAClass I

    Medline medical convenience kits

    Medline Industries, LP has identified through post-market surveillance a potential risk of the syringe rotating adaptor unwinding during use, which may result in a loose connection and/or full disconnection between the syringe and manifold.

  • FDAClass I

    Medline medical convenience kits

    Medline Industries, LP has identified through post-market surveillance a potential risk of the syringe rotating adaptor unwinding during use, which may result in a loose connection and/or full disconnection between the syringe and manifold.

  • FDAClass II

    Medline Convenience Kits containing select SKUs of 10mL Polycarbonate Colored Syringes ENSEMBLE GYNECO SCOPIE-LF

    Unapproved design changes to the products outside of the 510(k) clearance.

  • FDAClass II

    Medline Convenience Kits containing select SKUs of 10mL Polycarbonate Colored Syringes ARTERIOGRAM TRAY 00-402001T

    Unapproved design changes to the products outside of the 510(k) clearance.

  • FDAClass II

    Medline Convenience Kits containing select SKUs of 10mL Polycarbonate Colored Syringes ADD A ENDOVASCULAR PACK-LF

    Unapproved design changes to the products outside of the 510(k) clearance.

  • FDAClass II

    Medline Convenience Kits containing select SKUs of 10mL Polycarbonate Colored Syringes E P DRAPE PACK-LF DYNJ0373061J

    Unapproved design changes to the products outside of the 510(k) clearance.

  • FDAClass II

    Medline Convenience Kits containing select SKUs of 10mL Polycarbonate Colored Syringes ARTHROSCOPY PACK DYNJ45173D

    Unapproved design changes to the products outside of the 510(k) clearance.

  • FDAClass II

    Medline Convenience Kits containing select SKUs of 10mL Polycarbonate Colored Syringes EXTREMITY PACK DYNJ34846C

    Unapproved design changes to the products outside of the 510(k) clearance.

  • FDAClass II

    Medline Convenience Kits containing select SKUs of 10mL Polycarbonate Colored Syringes EYE PACK DYNJ35056A

    Unapproved design changes to the products outside of the 510(k) clearance.

  • FDAClass II

    Medline Convenience Kits containing select SKUs of 10mL Polycarbonate Colored Syringes GU DAVINCI PACK - LF

    Unapproved design changes to the products outside of the 510(k) clearance.

  • FDAClass II

    Medline Convenience Kits containing select SKUs of 10mL Polycarbonate Colored Syringes ANGIO KIT PACK DYNJ50783B

    Unapproved design changes to the products outside of the 510(k) clearance.

  • FDAClass II

    Medline Convenience Kits containing select SKUs of 10mL Polycarbonate Colored Syringes Medline Convenience Kits

    Unapproved design changes to the products outside of the 510(k) clearance.

  • FDAClass II

    Medline Convenience Kits containing select SKUs of 10mL Polycarbonate Colored Syringes FACE/RHINOPLASTY PACK

    Unapproved design changes to the products outside of the 510(k) clearance.

  • FDAClass II

    Medline Convenience Kits containing select SKUs of 10mL Polycarbonate Colored Syringes BARIATRIC DYNJ905153M

    Unapproved design changes to the products outside of the 510(k) clearance.

  • FDAClass II

    Medline Convenience Kits containing select SKUs of 10mL Polycarbonate Colored Syringes MINOR ENT SINUS PACK-LF

    Unapproved design changes to the products outside of the 510(k) clearance.

  • FDAClass II

    Medline Convenience Kits containing select SKUs of 10mL Polycarbonate Colored Syringes BIOPSY PACK DYNJ38587A

    Unapproved design changes to the products outside of the 510(k) clearance.

  • FDAClass II

    Medline Convenience Kits containing select SKUs of 10mL Polycarbonate Colored Syringes TAVR PACK DYNJ69246B

    Unapproved design changes to the products outside of the 510(k) clearance.

  • FDAClass II

    Medline Convenience Kits containing select SKUs of 10mL Polycarbonate Colored Syringes ADULT CATH PACK-LF

    Unapproved design changes to the products outside of the 510(k) clearance.

  • FDAClass II

    Medline Convenience Kits containing select SKUs of 10mL Polycarbonate Colored Syringes JUDKINS PACK DYNJ51126

    Unapproved design changes to the products outside of the 510(k) clearance.

  • FDAClass II

    Medline Syringes: 1) SYRINGE 12ML CONTROL W/ROTATOR

    The 510(k) regulatory clearances for certain Control Syringes, Guidewires, and/or High-Pressure Tubing have been rescinded.

  • FDAClass II

    Medline Namic Syringes: 1) SYR CNTRL 10ML RING W/ROT NB

    The 510(k) regulatory clearances for certain Control Syringes, Guidewires, and/or High-Pressure Tubing have been rescinded.

  • FDAClass II

    Medline Namic Guidewires: 1) GUIDEWIRE 3MMJ 0.035X260CM LT

    The 510(k) regulatory clearances for certain Control Syringes, Guidewires, and/or High-Pressure Tubing have been rescinded.

  • FDAClass II

    Medline Kits: 1) SYR CONTROL 8ML ROTATING

    The 510(k) regulatory clearances for certain Control Syringes, Guidewires, and/or High-Pressure Tubing have been rescinded.

  • FDAClass II

    Medline Kits: 1) SYR CNTRL 10ML RING W/ROT NB

    The 510(k) regulatory clearances for certain Control Syringes, Guidewires, and/or High-Pressure Tubing have been rescinded.

  • FDAClass II

    Medline Kits: 1) PICC TRAY

    The 510(k) regulatory clearances for certain Control Syringes, Guidewires, and/or High-Pressure Tubing have been rescinded.

  • FDAClass II

    Medline Kits: 1) NEWBORN ADMISSION

    The 510(k) regulatory clearances for certain Control Syringes, Guidewires, and/or High-Pressure Tubing have been rescinded.

  • FDAClass II

    Medline Kits: 1) MTS LEFT HEART KIT-CAROLINAS HOS, Model Number: 60021775; 2) DBD-MTS LHK BHS BAPTIST.

    The 510(k) regulatory clearances for certain Control Syringes, Guidewires, and/or High-Pressure Tubing have been rescinded.

  • FDAClass II

    Medline Kits: 1) LABOR PACK-22025208-LF

    The 510(k) regulatory clearances for certain Control Syringes, Guidewires, and/or High-Pressure Tubing have been rescinded.

  • FDAClass II

    Medline Kits: 1) HYSTEROSCOPY PACK

    The 510(k) regulatory clearances for certain Control Syringes, Guidewires, and/or High-Pressure Tubing have been rescinded.

  • FDAClass II

    Medline Kits: 1) HEART TRANSPLANT BIOPSY

    The 510(k) regulatory clearances for certain Control Syringes, Guidewires, and/or High-Pressure Tubing have been rescinded.

  • FDAClass II

    Medline Kits: 1) GYN LAPAROSCOPY PACK

    The 510(k) regulatory clearances for certain Control Syringes, Guidewires, and/or High-Pressure Tubing have been rescinded.

  • FDAClass II

    Medline Kits: 1) GENERAL LAPAROSCOPY

    The 510(k) regulatory clearances for certain Control Syringes, Guidewires, and/or High-Pressure Tubing have been rescinded.

  • FDAClass II

    Medline Kits: 1) ENT PACK

    The 510(k) regulatory clearances for certain Control Syringes, Guidewires, and/or High-Pressure Tubing have been rescinded.

  • FDAClass II

    Medline Kits: 1) D AND C PACK

    The 510(k) regulatory clearances for certain Control Syringes, Guidewires, and/or High-Pressure Tubing have been rescinded.

  • FDAClass II

    Medline Kits: 1) CATH LAB CDS

    The 510(k) regulatory clearances for certain Control Syringes, Guidewires, and/or High-Pressure Tubing have been rescinded.

  • FDAClass II

    Medline Kits: 1) BWNBORO CRANIOTOMY PACK-LF

    The 510(k) regulatory clearances for certain Control Syringes, Guidewires, and/or High-Pressure Tubing have been rescinded.

  • FDAClass II

    Medline Kits: 1) BREAST PACK

    The 510(k) regulatory clearances for certain Control Syringes, Guidewires, and/or High-Pressure Tubing have been rescinded.

  • FDAClass II

    Medline Kits: 1) ARTHROSCOPY PACK

    The 510(k) regulatory clearances for certain Control Syringes, Guidewires, and/or High-Pressure Tubing have been rescinded.

  • FDAClass II

    Medline Kits: 1) ARTHROGRAM TRAY

    The 510(k) regulatory clearances for certain Control Syringes, Guidewires, and/or High-Pressure Tubing have been rescinded.

  • FDAClass II

    Medline Kits: 1) ANGIOGRAPHY PACK-LF

    The 510(k) regulatory clearances for certain Control Syringes, Guidewires, and/or High-Pressure Tubing have been rescinded.

  • FDAClass II

    Medline Kits: 1) ANGIO CATH PACK-MARY IMMACULAT

    The 510(k) regulatory clearances for certain Control Syringes, Guidewires, and/or High-Pressure Tubing have been rescinded.

  • FDAClass II

    XTANT MEDICAL Xpress Pedicle Screw System Dual Lead 6.5 x 50 mm

    Units from one lot were mislabeled with an incorrect part number, identifying the device as a shorter screw length than it physically is.

  • FDAClass II

    React Health PHOENIX 5L Oxygen Concentrator

    Devices which did not meet internal quality specifications were inadvertently distributed.

  • FDAClass II

    On-X Mitral Heart Valve with Conform-X Sewing Ring

    Heart valves were released and distributed before all required testing was complete, so it cannot be confirmed that they meet all release specifications.

  • FDAClass II

    Diowave Laser System

    Software update is needed for laser systems, for topical infrared heating to provide temporary relief of minor muscle and joint pain, spasms, stiffness associated with minor arthritis, and to temporarily increase local blood circulation, operating at a maximum average power output of 70W, which is beyond the FDA cleared 60W.

  • FDAClass II

    See RES for full list.

    Medline has identified issues related to calibration of the equipment used to sterilize and package the devices. All products were exposed to the validated sterilization and packaging cycles; however, the identified calibration issues have the potential to impact the sterility assurance level (SAL) of the Recalled Products.

  • FDAClass II

    See RES for complete list.

    Medline has identified issues related to calibration of the equipment used to sterilize and package the devices. All products were exposed to the validated sterilization and packaging cycles; however, the identified calibration issues have the potential to impact the sterility assurance level (SAL) of the Recalled Products.

  • FDAClass II

    See RES for complete list.

    Medline has identified issues related to calibration of the equipment used to sterilize and package the devices. All products were exposed to the validated sterilization and packaging cycles; however, the identified calibration issues have the potential to impact the sterility assurance level (SAL) of the Recalled Products.

  • FDAClass II

    See RES for complete list.

    Medline has identified issues related to calibration of the equipment used to sterilize and package the devices. All products were exposed to the validated sterilization and packaging cycles; however, the identified calibration issues have the potential to impact the sterility assurance level (SAL) of the Recalled Products.

  • FDAClass II

    See RES for complete list.

    Medline has identified issues related to calibration of the equipment used to sterilize and package the devices. All products were exposed to the validated sterilization and packaging cycles; however, the identified calibration issues have the potential to impact the sterility assurance level (SAL) of the Recalled Products.

  • FDAClass II

    See RES for complete list.

    Medline has identified issues related to calibration of the equipment used to sterilize and package the devices. All products were exposed to the validated sterilization and packaging cycles; however, the identified calibration issues have the potential to impact the sterility assurance level (SAL) of the Recalled Products.

  • FDAClass II

    See full list in RES

    Medline has identified issues related to calibration of the equipment used to sterilize and package the devices. All products were exposed to the validated sterilization and packaging cycles; however, the identified calibration issues have the potential to impact the sterility assurance level (SAL) of the Recalled Products.

  • FDAClass II

    See complete list in RES, exceeds character limit.

    Medline has identified issues related to calibration of the equipment used to sterilize and package the devices. All products were exposed to the validated sterilization and packaging cycles; however, the identified calibration issues have the potential to impact the sterility assurance level (SAL) of the Recalled Products.

  • FDAClass II

    Medline Surgical Packs: 1) PACK

    Medline has identified issues related to calibration of the equipment used to sterilize and package the devices. All products were exposed to the validated sterilization and packaging cycles; however, the identified calibration issues have the potential to impact the sterility assurance level (SAL) of the Recalled Products.

  • FDAClass II

    Medline Surgical Drapes: 1) SHEET

    Medline has identified issues related to calibration of the equipment used to sterilize and package the devices. All products were exposed to the validated sterilization and packaging cycles; however, the identified calibration issues have the potential to impact the sterility assurance level (SAL) of the Recalled Products.

  • FDAClass II

    Medline Convenience Kits: 1) WMC I D PACK-LF

    Medline has identified issues related to calibration of the equipment used to sterilize and package the devices. All products were exposed to the validated sterilization and packaging cycles; however, the identified calibration issues have the potential to impact the sterility assurance level (SAL) of the Recalled Products.

  • FDAClass II

    Medline Convenience Kits: 1) SCC RF PAIN MGMT

    Medline has identified issues related to calibration of the equipment used to sterilize and package the devices. All products were exposed to the validated sterilization and packaging cycles; however, the identified calibration issues have the potential to impact the sterility assurance level (SAL) of the Recalled Products.

  • FDAClass II

    Medline Convenience Kits: 1) PPE KIT

    Medline has identified issues related to calibration of the equipment used to sterilize and package the devices. All products were exposed to the validated sterilization and packaging cycles; however, the identified calibration issues have the potential to impact the sterility assurance level (SAL) of the Recalled Products.

  • FDAClass II

    Medline Convenience Kits: 1) PICC LINE TRAY

    Medline has identified issues related to calibration of the equipment used to sterilize and package the devices. All products were exposed to the validated sterilization and packaging cycles; however, the identified calibration issues have the potential to impact the sterility assurance level (SAL) of the Recalled Products.

  • FDAClass II

    Medline Convenience Kits: 1) PICC CATHETER INSERTION TRAY

    Medline has identified issues related to calibration of the equipment used to sterilize and package the devices. All products were exposed to the validated sterilization and packaging cycles; however, the identified calibration issues have the potential to impact the sterility assurance level (SAL) of the Recalled Products.

  • FDAClass II

    Medline Convenience Kits: 1) OB KIT

    Medline has identified issues related to calibration of the equipment used to sterilize and package the devices. All products were exposed to the validated sterilization and packaging cycles; however, the identified calibration issues have the potential to impact the sterility assurance level (SAL) of the Recalled Products.

  • FDAClass II

    Medline Convenience Kits: 1) NEURO SHUNT- CODMAN

    Medline has identified issues related to calibration of the equipment used to sterilize and package the devices. All products were exposed to the validated sterilization and packaging cycles; however, the identified calibration issues have the potential to impact the sterility assurance level (SAL) of the Recalled Products.

  • FDAClass II

    Medline Convenience Kits: 1) LVAD DRIVELINE TRAY

    Medline has identified issues related to calibration of the equipment used to sterilize and package the devices. All products were exposed to the validated sterilization and packaging cycles; however, the identified calibration issues have the potential to impact the sterility assurance level (SAL) of the Recalled Products.

  • FDAClass II

    Medline Convenience Kits: 1) LITHOTOMY PACK

    Medline has identified issues related to calibration of the equipment used to sterilize and package the devices. All products were exposed to the validated sterilization and packaging cycles; however, the identified calibration issues have the potential to impact the sterility assurance level (SAL) of the Recalled Products.

  • FDAClass II

    Medline Convenience Kits: 1) KIT UROLOGY SLING

    Medline has identified issues related to calibration of the equipment used to sterilize and package the devices. All products were exposed to the validated sterilization and packaging cycles; however, the identified calibration issues have the potential to impact the sterility assurance level (SAL) of the Recalled Products.

  • FDAClass II

    Medline Convenience Kits: 1) KIT TRIPLE LUMEN INSERTION

    Medline has identified issues related to calibration of the equipment used to sterilize and package the devices. All products were exposed to the validated sterilization and packaging cycles; however, the identified calibration issues have the potential to impact the sterility assurance level (SAL) of the Recalled Products.

  • FDAClass II

    Medline Convenience Kits: 1) KIT SURG ONC EXCISION BREAST

    Medline has identified issues related to calibration of the equipment used to sterilize and package the devices. All products were exposed to the validated sterilization and packaging cycles; however, the identified calibration issues have the potential to impact the sterility assurance level (SAL) of the Recalled Products.

  • FDAClass II

    Medline Convenience Kits: 1) KIT STC TRACHEOSTOMY

    Medline has identified issues related to calibration of the equipment used to sterilize and package the devices. All products were exposed to the validated sterilization and packaging cycles; however, the identified calibration issues have the potential to impact the sterility assurance level (SAL) of the Recalled Products.

  • FDAClass II

    Medline Convenience Kits: 1) KIT OPHTHALMIC RUPTURE GLOBE

    Medline has identified issues related to calibration of the equipment used to sterilize and package the devices. All products were exposed to the validated sterilization and packaging cycles; however, the identified calibration issues have the potential to impact the sterility assurance level (SAL) of the Recalled Products.

  • FDAClass II

    Medline Convenience Kits: 1) KIT GENERAL CLOSURE

    Medline has identified issues related to calibration of the equipment used to sterilize and package the devices. All products were exposed to the validated sterilization and packaging cycles; however, the identified calibration issues have the potential to impact the sterility assurance level (SAL) of the Recalled Products.

  • FDAClass II

    Medline Convenience Kits: 1) HYSTEROSCOPY

    Medline has identified issues related to calibration of the equipment used to sterilize and package the devices. All products were exposed to the validated sterilization and packaging cycles; however, the identified calibration issues have the potential to impact the sterility assurance level (SAL) of the Recalled Products.

  • FDAClass II

    Medline Convenience Kits: 1) DYNDA3003

    Medline has identified issues related to calibration of the equipment used to sterilize and package the devices. All products were exposed to the validated sterilization and packaging cycles; however, the identified calibration issues have the potential to impact the sterility assurance level (SAL) of the Recalled Products.

  • FDAClass II

    Medline Convenience Kits: 1) DRAPE PACK

    Medline has identified issues related to calibration of the equipment used to sterilize and package the devices. All products were exposed to the validated sterilization and packaging cycles; however, the identified calibration issues have the potential to impact the sterility assurance level (SAL) of the Recalled Products.

  • FDAClass II

    Medline Convenience Kits: 1) DRAPE PACK-CHOICE

    Medline has identified issues related to calibration of the equipment used to sterilize and package the devices. All products were exposed to the validated sterilization and packaging cycles; however, the identified calibration issues have the potential to impact the sterility assurance level (SAL) of the Recalled Products.

  • FDAClass II

    Medline Convenience Kits: 1) CVC PACK

    Medline has identified issues related to calibration of the equipment used to sterilize and package the devices. All products were exposed to the validated sterilization and packaging cycles; however, the identified calibration issues have the potential to impact the sterility assurance level (SAL) of the Recalled Products.

  • FDAClass II

    Medline Convenience Kits: 1) CHEST TUBE INSERTION TRAY

    Medline has identified issues related to calibration of the equipment used to sterilize and package the devices. All products were exposed to the validated sterilization and packaging cycles; however, the identified calibration issues have the potential to impact the sterility assurance level (SAL) of the Recalled Products.

  • FDAClass II

    Medline Convenience Kits: 1) CENTRAL LINE UNIVERSAL INSERTI

    Medline has identified issues related to calibration of the equipment used to sterilize and package the devices. All products were exposed to the validated sterilization and packaging cycles; however, the identified calibration issues have the potential to impact the sterility assurance level (SAL) of the Recalled Products.

  • FDAClass II

    Medline Convenience Kits: 1) C-SECTION PACK

    Medline has identified issues related to calibration of the equipment used to sterilize and package the devices. All products were exposed to the validated sterilization and packaging cycles; however, the identified calibration issues have the potential to impact the sterility assurance level (SAL) of the Recalled Products.

  • FDAClass II

    Medline Convenience Kits: 1) BASIC NERVE BLOCK TRAY W/LINEN

    Medline has identified issues related to calibration of the equipment used to sterilize and package the devices. All products were exposed to the validated sterilization and packaging cycles; however, the identified calibration issues have the potential to impact the sterility assurance level (SAL) of the Recalled Products.

  • FDAClass II

    Medline Convenience Kits: 1) BAPTIST FLOYD ENDO GI KIT

    Medline has identified issues related to calibration of the equipment used to sterilize and package the devices. All products were exposed to the validated sterilization and packaging cycles; however, the identified calibration issues have the potential to impact the sterility assurance level (SAL) of the Recalled Products.

  • FDAClass II

    Medline Convenience Kits: 1) BAP NORTH ROBOTIC SURGERY CDS

    Medline has identified issues related to calibration of the equipment used to sterilize and package the devices. All products were exposed to the validated sterilization and packaging cycles; however, the identified calibration issues have the potential to impact the sterility assurance level (SAL) of the Recalled Products.

  • FDAClass II

    Medline Convenience Kits: 1) ARTHROSCOPY CDS

    Medline has identified issues related to calibration of the equipment used to sterilize and package the devices. All products were exposed to the validated sterilization and packaging cycles; however, the identified calibration issues have the potential to impact the sterility assurance level (SAL) of the Recalled Products.

  • FDAClass II

    Medline Convenience Kits: 1) ANGIO PROCEDURE PACK

    Medline has identified issues related to calibration of the equipment used to sterilize and package the devices. All products were exposed to the validated sterilization and packaging cycles; however, the identified calibration issues have the potential to impact the sterility assurance level (SAL) of the Recalled Products.

  • FDAClass II

    Medline Convenience Kits: 1) ANGIO PROCEDURE PACK

    Medline has identified issues related to calibration of the equipment used to sterilize and package the devices. All products were exposed to the validated sterilization and packaging cycles; however, the identified calibration issues have the potential to impact the sterility assurance level (SAL) of the Recalled Products.

  • FDAClass II

    Medline Convenience Kits: 1) ANCILLARY PACK-LF

    Medline has identified issues related to calibration of the equipment used to sterilize and package the devices. All products were exposed to the validated sterilization and packaging cycles; however, the identified calibration issues have the potential to impact the sterility assurance level (SAL) of the Recalled Products.

  • FDAClass II

    Medline Convenience Kits: 1) ADMIT KIT

    Medline has identified issues related to calibration of the equipment used to sterilize and package the devices. All products were exposed to the validated sterilization and packaging cycles; however, the identified calibration issues have the potential to impact the sterility assurance level (SAL) of the Recalled Products.

2025 (1)

  • FDAClass II

    iLet Ace Pump Kit REF: BB1001 iLet Dosing Decision Software

    it was found that in versions 1.3.7, 1.4.2, and 1.4.3, the Lock Screen and Limited Access Passcode Screen on the iLet graphical user interface (GUI) include certain icons displayed in the status bar that are active, thereby allowing the user to bypass those screens when those icons on the status bar are pressed, allowing unauthorized access while the device is in Limited Access Mode. A Health Risk associated with Limited access mode includes severe hypoglycemia due to unauthorized access to the iLet if someone were to make unauthorized meal announcements or stopped insulin delivery.

Independent news on labor, safety, and accountability.